CovidVax | show full list |
limited distribution: Q2 2021 mass distribution: Q4 2021 (1 billion doses) |
Jul 06 | Emergent will produce drug substance at large scale on a five year agreement with Janssen (by biospace.com) |
Apr 15 | 1B+ dosis of J&J's vaccine could be produced by Q4 2021 with potential other partners (by bioprocessintl.com) |
Mar 30 | Johnson & Johnson is hopeful to deliver a vaccine for emergency use in early 2021 (by prnewswire.com) |
PHASE 1 (Japan)
started August 11 2020 with 250 healthy volunteers aged 20+ trial location: Japan |
PHASE 1-2 (USA/Belgium)
started July 13 2020 with 1045 healthy volunteers aged 18+ trial location: USA and Belgium |
PHASE 2
started August 28 2020 with 550 healthy volunteers aged 18+ trial location: several countries |
PHASE 3
started September 5 2020 with 60000 healthy volunteers aged 18+ trial location: several countries |
PHASE 3
started November 6 2020 with 30000 healthy volunteers aged 18+ trial location: several countries |
start date: March 2020 |
Sep 03 | Janssen's vaccine prevented severe clinical disease in preclinical studies on Syrian golden hamsters (by jnj.com) |
Sep 03 | Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters (by nature.com) |
Jul 30 | Ad26 vaccine's single shot gives protection against SARS-CoV-2 in rhesus macaques (by nature.com) |
Mar 30 | Johnson & Johnson announced the selection of 1 lead candidate vaccine (by jnj.com) |
Mar 18 | J&J is using the same platform of Ebola vaccine, which will allow it to “go very fast" (by fiercebiotech.com) |
Mar 13 | Janssen have started preclinical testing of multiple vaccine candidates (by massdevice.com) |
currently no early development info |
Aug 13 | J&J have tied up with BE for coronavirus vaccine production to be launched in India by mid 2021 (by indiatimes.com) |
Aug 05 | HHS and DOD partner with Johnson & Johnson to produce million of doses of its vaccine (by medicalcountermeasures.gov) |
Jul 17 | J&J is in talks with Japanese government and Gates Foundation to supply doses of its vaccine (by fiercepharma.com) |
Apr 29 | Catalent's partnership with J&J will accelerate manufacturing capacity of the vaccine (by businesswire.com) |
Apr 23 | J&J and Emergent made a $135 million agreement to manufacture the vaccine (by emergentbiosolutions.com) |
Mar 13 | J&J announces collaboration with the Beth Israel Deaconess Medical Center (by jnj.com) |